Antisnakevenom: an over-used medication.
Fifty-five cases of snakebite were retrospectively analysed for the indications for the use of anti-snakevenom (ASV). Sixty-seven per cent of patients received treatment with ASV. Of these, 47% had features of systemic envenoming, 30% had features of local envenoming and 22% had no features of envenoming, either systemic or local. When WHO guidelines were strictly applied, it was found that in 44% of cases, ASV was used without adequate indication.
Thachil
R T
RT
Department of Medicine, St John's Medical College Hospital, Bangalore, India.
Tony
J C
JC
Jude
E
E
Ross
C
C
Vincent
N D
ND
Sridhar
C B
CB
D000997:Antivenins / Q000627:therapeutic use*; D006801:Humans; D012189:Retrospective Studies; D012909:Snake Bites / Q000628:therapy*
D000997:Antivenins